scispace - formally typeset
M

Michael Hughes

Researcher at Royal Hallamshire Hospital

Publications -  615
Citations -  26328

Michael Hughes is an academic researcher from Royal Hallamshire Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 74, co-authored 531 publications receiving 24066 citations. Previous affiliations of Michael Hughes include Royal College of Physicians & St Thomas' Hospital.

Papers
More filters
Journal ArticleDOI

Antiretroviral therapy during pregnancy and the risk of an adverse outcome

TL;DR: Findings provide reassurance that there is a low risk of adverse pregnancy outcomes from antiretroviral treatment, and whatever increased risk exists is likely to be counterbalanced by the acknowledged benefits of antireteviral treatment during pregnancy.
Journal ArticleDOI

An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients

TL;DR: The main tool to screen PAH is transthoracic echocardiography (TTE), which has a sensitivity of 90%, even if definitive diagnosis should be confirmed by right heart catheterization (RHC).
Journal ArticleDOI

The Design of Single-Arm Clinical Trials of Combination Antiretroviral Regimens for Treatment-Naive HIV-Infected Patients

TL;DR: Key design considerations for single-arm clinical trials to establish initial estimates of efficacy and safety/tolerability of novel regimens to inform the design of large phase III trials are discussed.
Journal ArticleDOI

Drug Development Strategies for Salvage Therapy: Conflicts and Solutions

TL;DR: This work focuses much of its discussion on salvage studies of antiviral drugs, as pharmaceutical companies drive much of the current research agenda and can largely specify how they would like their agents to be tested.
Journal ArticleDOI

Anabolic androgenic steroid induced necrotising myopathy

TL;DR: A 23-year-old gentleman who developed a severe generalised necrotising myopathy required intensive care support from the development of multi-organ failure after investigations failed to demonstrate an infective, inflammatory, metabolic or inherited aetiology.